Search
Managing peripheral vascular disease through the COVID-19 epidemic curve
Dr. Frank Arko, Dr. James McKinsey, and Dr. Craig Walker will share their experiences in response to the unprecedented measures taken across the country to prepare for COVID-19 and protect the safety of employees and patients alike.Adapting to an unprecedented crisis: how are office based labs responding
Discussion to share and define best practices developing in real-time in response to the COVID-19 pandemic especially as it relates to outpatient peripheral vascular practices.My experience with Symphony Suite with Dr. Foluso Fakorede
Foluso Fakorede, MD, shares his thoughts on Symphony Suite and how it has benefited his practice and his community.Fighting CLI: Imaging and treatment algorithm
Watch a recorded case presentation with panel discussion from AMP. The discussion focuses on combining imaging and endovascular therapy into the CLI algorithm.What does "See Clearly. Treat Optimally." Mean to You? with Bryan Fisher, MD
Bryan Fisher, MD, shares his thoughts on intravascular ultrasound and how it helps him "See Clearly. Treat Optimally."How Does Philips Help you "Treat Optimally?"
George Adams, MD, explains why it is important to "Treat Optimally" in his practice. He believe Philips allows him to personalize care for each of his patients with the tools given to him.What Does "See Clearly. Treat Optimally" Mean to You?
George Adams, MD, shares his thoughts on Philips motto of "See Clearly. Treat Optimally" and how he ties it into his daily practice.IVUS guided Phoenix atherectomy system case study: Tibial access and treatment
Christoper LeSar, MD, presents a case study on Phoenix atherectomy system with the tibial access approach.IVUS guided Phoenix atherectomy system case study: SFA treatment
Christopher LeSar, MD, presents a case study with the Phoenix atherectomy system on a 76 year old woman who had 75% lesion in the superficial femoral system and then multi-level tibial obstructive disease with single vessel perineal artery runoff.Stellarex Paclitaxel Animation
Stellarex is the only low-dose* drug-coated balloon (DCB) to demonstrate a significant treatment effect and high safety profile through 3 years in all patients—common to complex.Back to life faster and healthier
With thousands of educational events around the world, Philips works with its partners to place a global spotlight on thrombosis as an urgent and growing health problem. Our goal is to focus attention on the often overlooked and misunderstood condition of thrombosis and work on creating meaningful impact in the venous space.See clearly. Treat optimally.
Visualize the best path forward with IVUS eyes Philips IVUS provides the visualization needed to gain deeper insights into the lesion and choose the best procedural path forward.